Pharmacovigilance Blog

Drug safety and pharmacovigilance

Pharmacovigilance – The Basics

In this comprehensive blog, where we provide a comprehensive overview of pharmacovigilance. Whether you’re new to the field or seeking a refresher, our blog is here to guide you through the basics of pharmacovigilance.

Bala

Read

Techs & Tools

Save Business Expenses: 6 Free Tools for Email Collection

In this article, I briefly provide an overview of the resources I use to collect emails for my business development with no costs. Although it is time-consuming process and may not suitable for everyone, I still share my experience for those starting a business on a limited budget might helpful.

Bala

Read

Drug safety and pharmacovigilance

Understanding Action Items in pharmacovigilance

From this insightful blog, where you can learn all about action items and provide guidance on how to handle them promptly in various circumstances. By the end of this blog, you’ll have the knowledge to confidently address action items and drive progress.

Bala

Read

ICSR Management

Causality Assessment in PV: The Criteria and Category

Welcome to our blog, where we demystify the concept of causality assessment in the pharmacovigilance process. We understand that grasping the criteria and categories of causality assessment can sometimes be challenging. That’s why we’re here to simplify it for you, presenting the information in an easy-to-understand manner.

Bala

Read

ICSR Management

Crafting a Well-Structured ICSR Narrative

Within this extensive pharmacovigilance blog, specifically focusing on Individual Case Safety Reports (ICSRs), we meticulously construct a model narrative, line by line, outlining the essential information to be incorporated. By engaging with this content, you’ll acquire valuable insights into narrative writing within the context of ICSR reporting.

Bala

Read

Exploring Adverse Events

Counterfeit Drugs: An Adverse Event

In this comprehensive article, we delve into the world of counterfeit medicines. We explore what they are, how they are classified as adverse events, and the considerations involved.

Bala

Read

Drug safety and pharmacovigilance

Understanding Civil Money Penalties

In this pharmacovigilance blog, we will delve into the details of civil penalties, addressing any uncertainties regarding the amount of penalties for late submissions or the provision of misleading data. Take a moment to read and gain clarity through this blog. Happy reading!

Bala

Read

Drug safety and pharmacovigilance

Validating Incident Country: Key in Case Processing

Welcome to our informative pharmacovigilance blog, where we explore the significance of the country of incidence in ICSR (Individual Case Safety Report) case processing and its potential impact on the outcome of the case. Join in our journey through the world of pharmacovigilance.

Bala

Read